Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #116

Zuidersma, M., Chua, K.C., Hellier, J., Voshaar, R.O., Banerjee, S. & HTA-SADD Investigator Group. (2019). Sertraline and mirtazapine versus placebo in subgroups of depression in dementia: Findings from the HTA-SADD randomized controlled trial. Am J Geriatr Psychiatry. 27(9), 920-931. doi: 10.1016/j.jagp.2019.03.021.